Q1 2024 |
77 |
$2.72 B |
+$468 M |
-$882 M |
-$414 M |
KRYS, FOLD, IMNM, SRRK, FATE
|
13F-HR |
5/15/2024, 04:50 PM |
Q4 2023 |
70 |
$2.8 B |
+$465 M |
-$319 M |
+$145 M |
IMGN, KRYS, FOLD, SRRK, RYZB
|
13F-HR |
2/14/2024, 04:16 PM |
Q3 2023 |
68 |
$2.1 B |
+$137 M |
-$372 M |
-$235 M |
IMGN, KRYS, FOLD, AKRO, AUGX
|
13F-HR |
11/14/2023, 04:15 PM |
Q2 2023 |
72 |
$2.61 B |
+$487 M |
-$443 M |
+$43.5 M |
IMGN, KRYS, FOLD, REPL, AKRO
|
13F-HR |
8/14/2023, 04:15 PM |
Q1 2023 |
76 |
$2.3 B |
+$383 M |
-$273 M |
+$111 M |
FOLD, KRYS, ISEE, DCPH, AKRO
|
13F-HR |
5/15/2023, 04:15 PM |
Q4 2022 |
69 |
$2.44 B |
+$290 M |
-$327 M |
-$36.5 M |
FOLD, KRYS, AKRO, REPL, FATE
|
13F-HR |
2/14/2023, 04:18 PM |
Q3 2022 |
70 |
$2.58 B |
+$313 M |
-$485 M |
-$171 M |
FATE, FOLD, KRYS, ARGX, PLRX
|
13F-HR |
11/14/2022, 04:03 PM |
Q2 2022 |
71 |
$2.62 B |
+$296 M |
-$149 M |
+$147 M |
FATE, FOLD, SGEN, ARGX, KRYS
|
13F-HR |
8/15/2022, 05:22 PM |
Q1 2022 |
70 |
$3.2 B |
+$179 M |
-$180 M |
-$1.25 M |
FATE, FOLD, ARGX, LIVN, KRYS
|
13F-HR |
5/16/2022, 04:13 PM |
Q4 2021 |
71 |
$4.4 B |
+$449 M |
-$735 M |
-$286 M |
FATE, FOLD, SNCE, ARGX, LIVN
|
13F-HR |
2/14/2022, 05:07 PM |
Q3 2021 |
75 |
$5.73 B |
+$516 M |
-$714 M |
-$198 M |
FATE, ALLK, IGMS, ARGX, ADCT
|
13F-HR |
11/15/2021, 04:16 PM |
Q2 2021 |
86 |
$6.76 B |
+$476 M |
-$812 M |
-$336 M |
FATE, IGMS, BEAM, ARGX, FOLD
|
13F-HR |
8/16/2021, 05:00 PM |
Q1 2021 |
86 |
$7.1 B |
+$1.13 B |
-$1.4 B |
-$264 M |
FATE, ALLK, IGMS, ARGX, FOLD
|
13F-HR |
5/17/2021, 04:05 PM |
Q4 2020 |
87 |
$8.26 B |
+$1.61 B |
-$739 M |
+$872 M |
FATE, FOLD, ALLK, BEAM, IGMS
|
13F-HR |
2/16/2021, 04:06 PM |
Q3 2020 |
81 |
$5.45 B |
+$1.15 B |
-$1.07 B |
+$83.4 M |
FATE, FOLD, IMMU, ARGX, IGMS
|
13F-HR |
11/16/2020, 04:09 PM |
Q2 2020 |
80 |
$5.42 B |
+$1.48 B |
-$724 M |
+$755 M |
FATE, FOLD, DCPH, ADCT, ARGX
|
13F-HR |
8/14/2020, 04:16 PM |
Q1 2020 |
69 |
$3.57 B |
+$674 M |
-$674 M |
+$230 K |
FATE, FOLD, DCPH, BIIB, IGMS
|
13F-HR |
5/15/2020, 04:04 PM |
Q4 2019 |
64 |
$4.18 B |
+$1.11 B |
-$854 M |
+$260 M |
DCPH, ALLK, FOLD, FATE, EPZM
|
13F-HR |
2/14/2020, 04:10 PM |
Q3 2019 |
74 |
$2.99 B |
+$709 M |
-$838 M |
-$129 M |
ALLK, FOLD, FATE, DCPH, ALDR
|
13F-HR |
11/14/2019, 04:11 PM |
Q2 2019 |
80 |
$3.53 B |
+$596 M |
-$639 M |
-$43.3 M |
ARRY, FOLD, FATE, ARGX, QURE
|
13F-HR |
8/14/2019, 04:04 PM |
Q1 2019 |
82 |
$3.42 B |
+$662 M |
-$300 M |
+$362 M |
ARRY, FOLD, FATE, ATRA, ARGX
|
RESTATEMENT |
5/17/2019, 08:56 PM |
Q4 2018 |
78 |
$2.49 B |
+$373 M |
-$590 M |
-$217 M |
ARRY, ATRA, FATE, XNCR, WVE
|
RESTATEMENT |
5/16/2019, 03:34 PM |
Q3 2018 |
83 |
$3.25 B |
+$699 M |
-$490 M |
+$209 M |
ARRY, ATRA, FATE, RGNX, XNCR
|
RESTATEMENT |
5/16/2019, 03:34 PM |
Q2 2018 |
81 |
$2.94 B |
+$705 M |
-$593 M |
+$112 M |
ARRY, FOLD, ATRA, IMGN, XNCR
|
13F-HR |
8/14/2018, 04:32 PM |
Q1 2018 |
64 |
$2.59 B |
+$592 M |
-$522 M |
+$69.6 M |
ARRY, ATRA, FOLD, IMGN, XNCR
|
13F-HR |
5/15/2018, 04:30 PM |
Q4 2017 |
1 |
$6.6 M |
$0 |
$0 |
|
LIFE
|
NEW HOLDINGS |
3/8/2018, 04:01 PM |
Q4 2017 |
70 |
$2.3 B |
+$678 M |
-$391 M |
+$288 M |
ARRY, FOLD, PBYI, CLVSQ, WVE
|
13F-HR |
2/14/2018, 05:03 PM |
Q3 2017 |
65 |
$2.03 B |
+$628 M |
-$467 M |
+$161 M |
ARRY, FOLD, PBYI, SGENXXXX, CLVSQ
|
13F-HR |
11/14/2017, 04:23 PM |
Q2 2017 |
62 |
$1.62 B |
+$374 M |
-$424 M |
-$50.1 M |
ARRY, FOLD, PEN, PBYI, CLVSQ
|
13F-HR |
8/14/2017, 05:39 PM |
Q1 2017 |
60 |
$1.54 B |
+$489 M |
-$303 M |
+$186 M |
ARRY, PEN, FOLD, PBYI, CLVSQ
|
13F-HR |
5/15/2017, 04:41 PM |
Q4 2016 |
50 |
$1.16 B |
+$246 M |
-$231 M |
+$15.5 M |
ARRY, SGENXXXX, CLVSQ, PEN, FOLD
|
13F-HR |
2/14/2017, 04:40 PM |
Q3 2016 |
51 |
$1.26 B |
+$383 M |
-$415 M |
-$31.7 M |
ARRY, SGENXXXX, FOLD, CLVSQ, GWPH
|
13F-HR |
11/14/2016, 06:26 PM |
Q2 2016 |
54 |
$1.05 B |
+$260 M |
-$255 M |
+$5.19 M |
ARRY, FOLD, MDVN, SGENXXXX, ATRA
|
13F-HR |
8/15/2016, 06:47 PM |
Q1 2016 |
46 |
$966 M |
+$246 M |
-$342 M |
-$95.5 M |
FOLD, MDVN, CLVSQ, PEN, ARRY
|
13F-HR |
5/16/2016, 05:22 PM |
Q4 2015 |
56 |
$1.3 B |
+$365 M |
-$380 M |
-$15.3 M |
FOLD, MDVN, PEN, ARRY, ITCI
|
13F-HR |
2/16/2016, 04:53 PM |
Q3 2015 |
58 |
$1.32 B |
+$735 M |
-$521 M |
+$214 M |
FOLD, CLVSQ, ARRY, MDVN, INCY
|
RESTATEMENT |
11/17/2015, 03:23 PM |
Q2 2015 |
55 |
$1.22 B |
+$394 M |
-$366 M |
+$27.5 M |
ARRY, FOLD, VRX, CLVSQ, TEVA
|
13F-HR |
8/14/2015, 04:27 PM |
Q1 2015 |
54 |
$1.11 B |
+$435 M |
-$346 M |
+$88.3 M |
ARRY, CLVSQ, FOLD, VRX, TEVA
|
13F-HR |
5/15/2015, 07:11 PM |
Q4 2014 |
54 |
$918 M |
+$210 M |
-$257 M |
-$47.3 M |
FOLD, ARRY, VRX, CMRX, RADXXXX
|
13F-HR |
2/17/2015, 07:28 PM |
Q3 2014 |
52 |
$812 M |
+$314 M |
-$345 M |
-$30.9 M |
VRX, B108PS, CLVSQ, CELG, FOLD
|
13F-HR |
11/14/2014, 04:29 PM |
Q2 2014 |
47 |
$822 M |
+$334 M |
-$328 M |
+$5.83 M |
B108PS, MDTXXXX, ARRY, UHS, HCA
|
13F-HR |
8/14/2014, 06:52 PM |
Q1 2014 |
55 |
$838 M |
+$363 M |
-$443 M |
-$80.4 M |
B108PS, HCA, A, VRX, CLVSQ
|
RESTATEMENT |
8/19/2014, 02:09 PM |
Q4 2013 |
55 |
$796 M |
$0 |
$0 |
|
GILD, CLVSQ, ZBH, CELG, AZN
|
13F-HR |
2/14/2014, 05:16 PM |